SEARCH

SEARCH BY CITATION

References

  • 1
    Collins R, Langman M. Treatment with histamine H2 antagonists in acute upper gastrointestinal hemorrhage: implications of randomized trials. N Engl J Med 1985; 313: 6606.
  • 2
    Walt RP, Cottrell J, Mann SG, Freemantle NP, Langman MJS. Continuous intravenous famotidine for haemorrhage from peptic ulcer. Lancet 1992; 340: 105862.
  • 3
    Fullarton GM, MacDonald AM, Mann SG, McColl KEL. Controlled study of the effects of intravenous famotidine on intragastric pH in bleeding peptic ulcers. Aliment Pharmacol Ther 1991; 5: 7784.
  • 4
    Petitti DB. Meta-analysis, decision analysis and cost-effectiveness analysis. Methods for quantitative synthesis in medicine. In: Monographs in Epidemiology and Biostatistics, Vol 24. Oxford: Oxford University Press, 1994: 11923.
  • 5
    Anonymous. Glossary. ACP Journal Club 2000; 133: A22.
  • 6
    Cook RJ, Sackett DL. The number needed to treat: a clinically useful measure of treatment effect. Br Med J 1995; 310: 4524.
  • 7
    Baltas B, Dobronte Z. Randomized prospective trial of cimetidine in the treatment of acute upper gastrointestinal haemorrhage. Acta Chir Hung 1984; 25: 14757.
  • 8
    Basso N, Bagarani M, Bracci F, et al. Ranitidine and somatostatin: their effects on bleeding from the upper gastrointestinal tract. Arch Surg 1986; 121: 8335.
  • 9
    Gray BN, De Zwart J, Andrewarthur L, Crowley S, Kamm M, Watson K. Controlled clinical trial of ranitidine in bleeding peptic ulcer. Aust NZ J Surg 1986; 56: 7237.
  • 10
    Coraggio F, Bertini G, Catalano A, Scarpato P, Gualdieri L. Clinical controlled trial of somatostatin with ranitidine and placebo in the control of peptic hemorrhage of the upper gastrointestinal tract. Digestion 1989; 43: 1905.
  • 11
    Khuroo MS, Yattoo GN, Javid G, et al. A comparison of omeprazole and placebo for bleeding peptic ulcer. N Engl J Med 1997; 336: 10548.
  • 12
    Javid G, Masoodi I, Zargar SA, et al. Omeprazole as adjuvant therapy to endoscopic combination injection sclerotherapy for treating bleeding peptic ulcer. Am J Med 2001; 111: 2804.
  • 13
    Lau JYW, Sung JJY, Lee KKC, et al. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. N Engl J Med 2000; 343: 3106.
  • 14
    Brunner G, Luna P, Hartmann M, Wurst W. Optimizing the intragastric pH as a supportive therapy in upper GI bleeding. Yale J Biol Med 1996; 69: 22531.
  • 15
    Sackier IE, Halliday K, Sprott P, Coelho LGV, Batten JJ, Li SK. The effects of intravenous omeprazole on 24 h gastric secretion in healthy subjects. Comparisons of continuous and intermittent infusions: a pilot study. Eur J Gastroenterol Hepatol 1991; 3: 67984.
  • 16
    Netzer P, Gaia C, Sandoz M, et al. Effect of repeated injection and continuous infusion of omeprazole and ranitidine on intragastric pH over 72 hours. Am J Gastroenterol 1999; 94: 3517.
  • 17
    Killerich S, Rannem T, Elsborg L. Effect of intravenous infusion of omeprazole and ranitidine on twenty-four-hour intragastric pH in patients with a history of duodenal ulcer. Digestion 1995; 56: 2530.
  • 18
    Fried R, Beglinger C, Stumpf J, et al. Comparison of intravenous pantoprazole with intravenous ranitidine in peptic ulcer bleeding. Gastroenterology 1999; 116: A165(Abstract).
  • 19
    Duvnjak M, Supanc V, Troskot B, et al. Comparison of intravenous pantoprazole with intravenous ranitidine in prevention of rebleeding from gastroduodenal ulcers. Gut 2001; 49(Suppl. III): A2379(Abstract).